Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Apr 23;16(4):e58866.
doi: 10.7759/cureus.58866. eCollection 2024 Apr.

Monkeypox: From Emerging Trends to Therapeutic Concerns

Kiran G Piparva  1 , Nilesh Fichadiya  2 , Tejal Joshi  3 , Shahenaz Malek  4
Affiliations
Review

Monkeypox: From Emerging Trends to Therapeutic Concerns

Kiran G Piparva et al. Cureus. .

Abstract

Monkeypox is a zoonotic viral disease. Monkeypox was first reported in humans about 54 years ago. Prior to the global outbreak, monkeypox was endemic to the rainforests of central and western African countries. In the last three years, increasing numbers of human monkeypox have been reported from various countries. Responding to the severity, monkeypox was declared a Public Health Emergency of International Concern by the World Health Organization. In the absence of approved drugs or clinical studies, repurposed drugs and therapeutic medical countermeasures effective against other orthopoxviruses have been utilized to treat severe human monkeypox cases. Currently, clinical trials are underway exploring the potential therapeutic effectiveness of tecovirimate in human monkeypox cases. Monoclonal antibodies, IFN-β, resveratrol, and 15 triple-targeting FDA-approved drugs represent potential new drug targets for human monkeypox, necessitating further research.

Keywords: bcv; hmxpv; mpox; oxpv; pheic; tecovirimat; vigiv.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Monkeypox: journey from virus isolation to global outbreak.
The figure illustrates the temporal progression of monkeypox, from its initial isolation in 1958 to a notable outbreak in 2022 [15-20]. DRC: Democratic Republic of Congo, PHEIC: Public Health Emergency of International Concern.
Figure 2
Figure 2. Global outbreak of monkeypox during 2022-2023.
This figure details outbreaks of mpox, showing confirmed cases in the regions of America, Africa, Europe, Southeast Asia, and the Eastern Mediterranean during 2022-2023 [23]. Source: Centers for Disease Control and Prevention (CDC). (Permission has been obtained.)
Figure 3
Figure 3. Evolution of skin rash in monkeypox infection
The figure illustrates the development of the skin lesions in monkeypox from a maculopapular rash to vesicles, pustules, and eventual scab formation over a period of 10-14 days [30,33]. Source: Centers for Disease Control and Prevention (CDC). (Permission has been obtained.)
See this image and copyright information in PMC

References

    1. Emergence of monkeypox as the most important orthopoxvirus infection in humans. Sklenovská N, Van Ranst M. Front Public Health. 2018;6:241. - PMC - PubMed
    1. A pox-like disease in cynomolgus monkeys. Magnus VP, Anderson EK, Petersen KB, Birch-Andersen A. https://doi.org/10.1111/j.1699-0463.1959.tb00328.x Acta Pathol Microbiol Scand. 1959;46:156–176.
    1. Monkeypox virus. Cho CT, Wenner HA. Bacteriol Rev. 1973;37:1–18. - PMC - PubMed
    1. The transmission potential of monkeypox virus in human populations. Fine PE, Jezek Z, Grab B, Dixon H. Int J Epidemiol. 1988;10:1093. - PubMed
    1. A human infection caused by monkeypox virus in Basankusu Territory, Democratic Republic of the Congo. Ladnyj ID, Ziegler P, Kima E. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480792/ Bull World Health Organ. 1972;46:593–597. - PMC - PubMed

LinkOut - more resources